Revision as of 08:14, 11 November 2024 edit76.174.0.57 (talk) Cat.← Previous edit | Latest revision as of 16:57, 15 January 2025 edit undoFswitzer4 (talk | contribs)Extended confirmed users11,001 editsm Added CAS RN | ||
Line 25: | Line 25: | ||
| excretion = | | excretion = | ||
<!--Identifiers--> | <!--Identifiers--> | ||
| CAS_number_Ref = {{cascite|correct|CAS}} | |||
| CAS_number = 4966-28-3 | | CAS_number = 4966-28-3 | ||
| UNII_Ref = {{fdacite|correct|FDA}} | |||
| UNII = QAH3JR2679 | |||
| ATC_prefix = | | ATC_prefix = | ||
| ATC_suffix = | | ATC_suffix = |
Latest revision as of 16:57, 15 January 2025
Chemical compound Pharmaceutical compoundIdentifiers | |
---|---|
IUPAC name
| |
CAS Number | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C12H16N2 |
Molar mass | 188.274 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
2,α-Dimethyltryptamine (2,α-DMT) is a tryptamine and a lesser-known psychedelic drug. It is the 2,α-dimethyl analog of DMT. Its synthesis was first reported in 1965. Alexander Shulgin lists the dosage as 300-500 mg, and the duration as 7–10 hours in his book TiHKAL (Tryptamines I Have Known and Loved). 2,α-DMT causes mydriasis and paresthesia. It also produces a calm, drunk-like feeling. Very little data exists about the pharmacological properties, metabolism, and toxicity of 2,α-DMT.
References
- Heath-Brown B, Philpott PG (1965). "Studies in the Indole Series. Part I. Indolylalkylamines". Journal of the Chemical Society (Dec): 7165–7178. doi:10.1039/jr9650007165.
- Shulgin A, Shulgin A (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. p. 422. ISBN 0-9630096-9-9. OCLC 38503252.
External links
This psychoactive drug-related article is a stub. You can help Misplaced Pages by expanding it. |